Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 4/20 | 0.45 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA7 | P43166 | 4/20 | 0.45 |
| ▸ | CA9 | Q16790 | 4/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384682 | 1.00 | HSD17B1 (0.56) | HSD17B1ALDH1A1CYP3A4HPGDMAPK1 | |
| SCHEMBL10370024 | 0.84 | CES2 (0.60) | HSD17B1ALDH1A1CYP3A4CES2CA12 | |
| SCHEMBL764844 | 0.84 | SMN1; SMN2 (0.50) | HSD17B1ALDH1A1CYP3A4HPGDCES2 | |
| SCHEMBL39526 | 0.82 | CA12 (0.61) | HSD17B1ALDH1A1CYP3A4HPGDCES2 | |
| SCHEMBL9216747 | 0.82 | HSD17B1 (0.47) | HSD17B1ALDH1A1CYP3A4HPGDMAPK1 | |
| SCHEMBL16520525 | 0.81 | ALDH1A1 (0.55) | HSD17B1ALDH1A1CYP3A4HPGDMAPK1 | |
| SCHEMBL14900218 | 0.80 | HSD17B1 (0.46) | HSD17B1ALDH1A1CYP3A4HPGDCES2 | |
| SCHEMBL27500611 | 0.80 | CA12 (0.59) | HSD17B1ALDH1A1CYP3A4HPGDCES2 | |
| SCHEMBL5952602 | 0.80 | MKNK1 (0.47) | HSD17B1ALDH1A1CES2CA12CA1 | |
| SCHEMBL27659033 | 0.80 | CA12 (0.59) | HSD17B1ALDH1A1CYP3A4HPGDCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 482 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114146071-B | Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome | 西北农林科技大学深圳研究院 | 2023-02-28 | — | — | CN | claimed |
| CN-114146071-A | Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome | 西北农林科技大学深圳研究院 | 2022-03-08 | — | — | CN | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250360486-A1 | Biorefining Method | LICELLA PTY LTD (AU) | 2025-11-27 | — | — | US | disclosed |
| US-20250346597-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | BEONE MEDICINES I GMBH (CH) | 2025-11-13 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12421193-B2 | GPR52 modulators and methods of use | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-12409437-B2 | Biorefining method | LICELLA PTY LTD (AU) | 2025-09-09 | — | — | US | disclosed |
| EP-0161105-A2 | Record material | APPLETON PAPERS INC. (US) | 1985-11-13 | — | — | EP | disclosed |
| US-4535347-A | HYDROXYANILIDES, PHENOLIC DEVELOPERS, CHROMOGENIC COMPOUNDS; BLOOMRESISTANCE | APPLETON PAPERS INC. (US) | 1985-08-13 | — | — | US | disclosed |
| US-4514416-A | Amidine compound, process for producing same and anti-complement agent comprising same | TORII & CO. LTD. (JP) | 1985-04-30 | — | — | US | disclosed |
| US-RE31715-E | ESTERS OF 2-METHYLBUTYLPHENOL | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1984-10-30 | — | — | US | disclosed |
| US-4470057-A | CHROMOGENIC COMPOUND, ACIDIC DEVELOPERS, AND PHENYLHYDROXYNAPHTHOATE | APPLETON PAPERS INC. (US) | 1984-09-04 | — | — | US | disclosed |
| EP-0100196-A2 | Thermally responsive record material | APPLETON PAPERS INC. (US) | 1984-02-08 | — | — | EP | disclosed |
| US-4394496-A | POLYEPOXEDES WITH GOOD HIGH TEMPERATURE PROPERTIES | THE DOW CHEMICAL COMPANY (US) | 1983-07-19 | — | — | US | disclosed |
| US-4195916-A | ELECTROOPTIC DISPLAY DEVICES, OPTICAL PHENOLIC ESTERS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1980-04-01 | — | — | US | disclosed |
| US-4029594-A | Novel liquid crystal compounds and electro-optic devices incorporating them | RCA CORPORATION (US) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | HSD17B1 318/4885ALDH1A1 1420/4885CYP3A4 1136/4885 |
| US-20250346597-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | DGKG, DGKA, DGKK | HSD17B1 2709/4885ALDH1A1 4075/4885CYP3A4 4471/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | HSD17B1 1461/4885ALDH1A1 4768/4885CYP3A4 1979/4885 |
| US-12421193-B2 | GPR52 modulators and methods of use | GPR52, GPR68, GPR35 | HSD17B1 1245/4885ALDH1A1 1831/4885CYP3A4 2659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.